Goodwin, Ernst & Young, Donnelley Financial Solutions (DFIN), and the Connor Group invite you to join us for our 2019 West Coast Life Sciences IPO Bootcamp, a half-day educational event for life sciences companies that are preparing for or considering an initial public offering (IPO) in the future.
Our program will include life sciences industry-focused panels on the key steps for preparing and executing an IPO and for life as a newly public company.
Topics will include:
- State of the IPO Market – Current market trends and outlook for IPOs in 2019/2020
- IPO Process Nuts and Bolts – What are the requirements for going public and how best to prepare for an IPO
- To Disclose or Not To Disclose – The SEC, the FDA and life science companies
- Fireside Chat with Chief Financial Officers – IPO insights from key life sciences companies that have recently gone public
Wednesday, October 30, 2019
2:30 – 7:30pm
2:30 pm – 3:00 pm | Registration
3:00 – 3:15 pm | Welcome/State of the IPO Market
3:15 – 4:15 pm | IPO Process Nuts and Bolts
4:15 – 5:00 pm | To Disclose or Not to Disclose
5:00 - 5:45 pm | Fireside Chat
5:45 - 6:00 pm | Closing Remarks
6:00 – 7:30 pm | Cocktail Reception
Goodwin's Silicon Valley Office
601 Marshall St | Redwood City, CA | 94063
Josh Bleharski, Managing Director, Healthcare Investment Banking, J.P. Morgan
Phil Howard, Partner, Ernst & Young
Priya Huskins, Senior Vice President, Management Liability, Woodruff Sawyer
Gil Labrucherie, Senior Vice President and Chief Financial Officer, Nektar Therapeutics
Jim Neesen, Managing Partner, Connor Group
Deepa Rich, Partner, Goodwin
Sujal Shah, President & CEO, CymaBay Therapeutics
Amit Sinha, Managing Director and Global Head of Biotechnology Investment Banking, Goldman Sachs
Brian Stephenson, Chief Financial Officer, BridgeBio Pharma, Inc.
Maggie Wong, Partner, Goodwin
Sam Zucker, Partner, Goodwin
To register, please click here.